Long-term Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From an Extension of Two Phase III, Vehicle-controlled Trials.
The Journal of clinical and aesthetic dermatology（2023）
摘要
E-BPO cream, 5%, showed a favorable safety and tolerability profile during this 40-week, open-label extension study.
更多查看译文
关键词
microencapsulated benzoyl peroxide cream,rosacea,long-term,vehicle-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要